Neurosense Therapeutics Ltd. (NRSN)
0.4251
+0.01
(+1.67%)
USD |
NASDAQ |
Sep 09, 09:58
Neurosense Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 3.760 |
| September 04, 2026 | 4.593 |
| September 03, 2026 | 3.611 |
| September 02, 2026 | 3.694 |
| September 01, 2026 | 3.778 |
| August 31, 2026 | 3.837 |
| August 28, 2026 | 3.780 |
| August 27, 2026 | 3.947 |
| August 26, 2026 | 3.678 |
| August 25, 2026 | 3.438 |
| August 24, 2026 | 3.372 |
| August 21, 2026 | 3.384 |
| August 20, 2026 | 3.151 |
| August 19, 2026 | 3.579 |
| August 18, 2026 | 3.435 |
| August 17, 2026 | 3.885 |
| August 14, 2026 | 4.075 |
| August 13, 2026 | 3.985 |
| August 12, 2026 | 4.215 |
| August 11, 2026 | 4.266 |
| August 10, 2026 | 4.354 |
| August 07, 2026 | 4.495 |
| August 06, 2026 | 4.523 |
| August 05, 2026 | 4.872 |
| August 04, 2026 | 4.675 |
| Date | Value |
|---|---|
| August 03, 2026 | 4.200 |
| July 31, 2026 | 4.183 |
| July 30, 2026 | 4.280 |
| July 29, 2026 | 4.318 |
| July 28, 2026 | 5.021 |
| July 27, 2026 | 5.279 |
| July 24, 2026 | 5.414 |
| July 23, 2026 | 5.890 |
| July 22, 2026 | 5.845 |
| July 21, 2026 | 6.295 |
| July 20, 2026 | 6.200 |
| July 17, 2026 | 6.151 |
| July 16, 2026 | 6.316 |
| July 15, 2026 | 6.465 |
| July 14, 2026 | 6.565 |
| July 13, 2026 | 6.565 |
| July 10, 2026 | 6.551 |
| July 09, 2026 | 6.474 |
| July 08, 2026 | 6.372 |
| July 07, 2026 | 6.368 |
| July 06, 2026 | 6.259 |
| July 02, 2026 | 6.367 |
| July 01, 2026 | 6.502 |
| June 30, 2026 | 6.475 |
| June 29, 2026 | 6.384 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.8057 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.774 |
| Can-Fite BioPharma Ltd. | 1.634 |
| Galmed Pharmaceuticals Ltd. | 0.3255 |
Price to Book Value Related Metrics
| Price | 0.4251 |
| Market Cap | 9.875M |